Anais Brasileiros de Dermatologia (Jan 2022)
104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain,
Abstract
No abstracts available.
Anais Brasileiros de Dermatologia (Jan 2022)